Company / Revenue per Share
Dare Bioscience, Inc. Revenue per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.00
FY2025
5-year range
$0.00 / $0.34
FY2021-FY2025
Trend
-99.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2022 to $0.80 in FY2014.
Based on SEC 10-K filings.
0.00 in FY2025 with a 10-year CAGR of +14.2%.
Declined from $0.12 to $0.00 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +14.2%
Key checks
Key Insights
- In FY2025, revenue per share decreased 99.7% year-over-year.
- Peak revenue per share was recorded in FY2014.
- Lowest revenue per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -99.7% |
| FY2024 | $0.34 | +185.9% |
| FY2023 | $0.12 | - |
| FY2022 | $0.00 | -100.0% |
| FY2016 | $0.00 | +881.2% |
| FY2015 | $0.00 | -100.0% |
| FY2014 | $0.80 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026